Application of a Non-Linear multi-model Ayurveda Intervention in elderly COVID-19 patients- a retrospective case series.

非线性多模型阿育吠陀干预在老年 COVID - 19 患者中的应用 - 回顾性病例系列。

• 发表时间: Jan-Mar 2022 2
• 来源期刊: J Ayurveda Integr Med
• DOI: 10.1016/j.jaim.2021.06.016
• PMID: 34230788
• 文章类型: Case Reports
• 作者列表: Dinesh KS,Nazeema PK,Archana M,Jayakrishnan K,Santhi Krishna AS,Swapna Chitra S,Sujitha VK,Sathian A,Girish Babu M,Balakrishnan G,Krishnendhu C

关键词: AYUSH, Ayurveda, yoga and naturopathy, Unani, Siddha and Homeopathy; Alternative medicine; Ayurveda; CAM, Complementary and alternative medicine; COVID-19; COVID-19, Corona Virus Disease- 2019; Co-morbidity; Elderly patients; NLMAI, Non-Linear multi-modal Ayurveda Intervention; NRIs, Non-Resident Indians; RT-PCR, Reverse Transcription-Polymerase Chain Reaction; SARS-CoV-2, Severe Acute Respiratory Syndrome Corona Virus-2; Survival function; Traditional medicine

Abstract

The COVID-19 pandemic is ravaging the world, leaving the mainstream medical system handicapped with no proven treatment at one end and the ambiguities regarding the efficacies of vaccines at the other. The elderly population is at greater risk in terms of complications and death. The use of complementary and alternative medicine (CAM) against COVID-19 has already been documented in countries like China with a national participation rate of 90%. In this regard, the practice of CAM especially Ayurveda is relevant in India. The current report is a case series of 64 elderly COVID-19 patients managed through a Non-Linear multi-modal Ayurveda Intervention (NLMAI) via online consultation. NLMAI is a combination of herbal and herbo-mineral drug interventions, lifestyle modifications, and psychological support done in 2 phases. The post-management analysis revealed a mean duration of 11 symptoms of COVID-19 assessed through survival function as 0.577 days [SE=0.39] with a CI of 95% [0.500-0.653] which was considerably low when compared to global statistics. Moreover, none of the cases advanced to complications or death. Hence, novel approaches like NLMAI can be utilized to counter the gravity of the COVID-19 after scientific validation.

摘要

■感染人数超过1.55亿，近32万人死亡,和数万亿的经济收费核算，COVID-19大流行正在肆虐世界。主流医疗系统正面临患者管理的挑战，一方面没有经过验证的治疗方法，另一方面却使用疫苗，在大流行期间发展群体免疫力和大规模疫苗接种的安全问题上普遍存在歧义。虽然疫苗接种是唯一的希望，它的功效缺乏愚蠢的证据证明。此外，65岁以上的成年人在并发症和死亡方面的风险更大.中国已经记录了使用中药对抗大流行的情况，全国参与率为90％。在这方面,使用补充和替代医学(CAM)对抗COVID-19是相关的，特别是在像印度这样的国家，它被广泛地作为阿育吠陀。
■当前报告是64名60岁以上的非居民印第安人（NRI）的回顾性病例系列，通过逆转录聚合酶链反应（RT-PCR）通过非线性多模态阿育吠陀干预（NLMAI）通过在线媒体咨询了21天。NLMAI是草药和草药矿物药物干预的组合，改变生活方式,心理支持分两个阶段进行。
■管理显示，通过COVID-19的11种症状的生存功能评估，症状的平均持续时间为0.577天[SE=0.39]，aCI95%[下限=0.500，上限0.653]，与全球统计数据相比相当低。此外，没有一例进展为并发症或死亡。整体，非线性，阿育吠陀的多模式方法可用于通过容易的症状恢复来对抗COVID-19大流行的严重性，共病管理和死亡。